Capital Research Global Investors’s Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A DHR.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-62,113
Closed -$136M 462
2021
Q4
$136M Buy
+62,113
New +$129M 0.03% 287
2020
Q4
Sell
-54,900
Closed -$81M 436
2020
Q3
$81M Hold
54,900
0.02% 287
2020
Q2
$68.5M Hold
54,900
0.02% 303
2020
Q1
$56.7M Hold
54,900
0.02% 279
2019
Q4
$64.7M Hold
54,900
0.02% 301
2019
Q3
$62.6M Hold
54,900
0.02% 303
2019
Q2
$60.6M Buy
54,900
+19,900
+57% +$21.1M 0.02% 298
2019
Q1
$36.9M Buy
+35,000
New +$36.1M 0.01% 342

Other funds holding DHR.PRA

Capital Research Global Investors's DHR.PRA Position: Q1 2022 in Review

Capital Research Global Investors sold out of Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A (DHR.PRA) in Q1 2022, closing a stake of 62,113 shares — an estimated $136M sold.

Capital Research Global Investors first reported a position in DHR.PRA in Q1 2019 and held it in 8 quarters. The position peaked at $136M in Q4 2021. 59 funds tracked by Wall St. Rank hold DHR.PRA as of Q1 2022.

  • Capital Research Global Investors reported no remaining Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A position as of Q1 2022 after selling out during the quarter.
  • Capital Research Global Investors sold 62,113 Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A shares in Q1 2022, an estimated $136M.
  • Capital Research Global Investors first reported a position in Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A in Q1 2019 and held it in 8 quarters.
  • Capital Research Global Investors's Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A position peaked at $136M in Q4 2021.
  • 59 funds tracked by Wall St. Rank held Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A as of Q1 2022.

Based on Capital Research Global Investors's 13F filing for Q1 2022, filed 16 May 2022.